Kiniksa Pharmaceuticals
KNSA
KNSA
228 hedge funds and large institutions have $2.18B invested in Kiniksa Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 75 increasing their positions, 85 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 223 → 228 (+5)
12% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 85
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
228
Holding in Top 10
3
Calls
$51.5M
Puts
$1.26M
Top Buyers
| 1 | +$230M | |
| 2 | +$22.4M | |
| 3 | +$22.1M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$18.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.1M |
Top Sellers
| 1 | -$54.4M | |
| 2 | -$29M | |
| 3 | -$18M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
Morgan Stanley
New York
|
-$16M |
